Studies Demonstrate Ipsen s Ongoing Commitment to Innovation and Improving Patient Care in Neuroendocrine Tumors Paris , 28 February 2019 - Ipsen today announced that.
/PRNewswire/ TerSera Therapeutics announced today a new sponsorship with the Carcinoid Cancer Foundation (CCF) and Alira Health to expand and optimize a.